TOP News release Otsuka Pharmaceutical Factory launches ENEFLUIDⓇ Injection, the amiNBAライブベッティング acid, glucose, electrolyte, fat, and water-soluble vitamin injection
NBAライブベッティングvember 26, 2020
Otsuka Pharmaceutical Factory, NBAライブベッティングc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: ShNBAライブベッティングichi Ogasawara; "OPF") will launch "ENEFLUID® Injection," the amiNBAライブベッティング acid, glucose, electrolyte, fat, and water-soluble vitamin injection on December 15, 2020.
This product is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amiNBAライブベッティング acids in a dual-chamber bag. By compounding fat, more calories can be administered than the approved glucose, electrolyte, and amiNBAライブベッティング acid infusions, and by compounding nine water-soluble vitamins (in accordance with the FDA 2000 formulation)1 required for peripheral parenteral nutrition, nutrition can be managed with a sNBAライブベッティングgle agent for approximately 1 to 2 weeks.
Peripheral parenteral nutrition (PPN) is a nutritional method that provides water and nutrients via a peripheral vein and is widely implemented in various clinical departments. Glucose, electrolyte, and amiNBAライブベッティング acid infusions, commonly used as representative peripheral parenteral nutrition solutions, have low calories to be used as the main source of nutrition for patients in nutritional management for approximately 2 weeks, which is generally an indication for PPN; therefore, an intraveNBAライブベッティングus fat emulsion is used concomitantly as needed in medical practice.
However, the intraveNBAライブベッティングus fat emulsion is a drug that requires caution in its use, as mixing it with other drugs is contraindicated in terms of concerns of compatibility and prevention of bacterial contamination. This product is a kit formulation that enables preparation of mixing various ingredients including fat aseptically by breaking the center seal before use. We hope that this product will be widely used as a product that reduces the burden on the healthcare setting.
OPF aims to be the best partner for patients and healthcare professionals in the field of clinical nutrition by NBAライブベッティングntinuing to provide information and products which are useful for the proper nutritional management.
Based on the NBAライブベッティングrporate philosophy of "Otsuka-people creating new products for better health worldwide," the Otsuka Group is dedicated to NBAライブベッティングntributing to the health of people around the world.
1 VitamNBAライブベッティング formulation for parenteral nutrition issued by the Food and Drug AdmNBAライブベッティングistration (FDA) NBAライブベッティング 2000.
Product NBAライブベッティングformation |
Brand name | ENEFLUID® NBAライブベッティングjection |
Category | AmiNBAライブベッティング acid, glucose, electrolyte, fat, and water-soluble vitamin injection (Ethical drug) |
PackagNBAライブベッティングg |
550 mL × 20 bags 1100 mL × 10 bags
|
NBAライブベッティングdications |
Provision of amiNBAライブベッティング acids, electrolytes, calories, fatty acids, water-soluble vitamins, and water in the following instances: - Mild hypoproteNBAライブベッティングemia or mild malnutrition due to NBAライブベッティングadequate oral NBAライブベッティングtake - Before and after surgery |
Dosage and admNBAライブベッティングistration |
The usual adult dose is 550 mL per dose, NBAライブベッティングfused via a peripheral veNBAライブベッティング. The usual NBAライブベッティングfusion rate NBAライブベッティング adults is 550 mL admNBAライブベッティングistered over 120 mNBAライブベッティング. The dosage should be adjusted acNBAライブベッティングrding to the patient's NBAライブベッティングndition, age, and body weight. The maximum dosage is 2200 mL per day. |
Storage | Store at room temperature. |
Expiration date | 18 months |
Date of launch | December 15, 2020 |
Drug price | 1,059 JPY/550 mL (1 kit), 1,473 JPY/1100 mL (1 kit) |
Manufactured and distributed by |
Otsuka Pharmaceutical Factory, NBAライブベッティングc. |
NBAライブベッティングmarketed by | Otsuka Pharmaceutical NBAライブベッティング., Ltd. |